Investor Library

StemRIMIR LibraryTimely Disclosure Information
February 15, 2024 Timely Disclosure Information StemRIM Announces Patent Registration (Japan) for Redasemtide as an Additional Therapeutic Indication of Traumatic Brain Injury 
February 14, 2024 Timely Disclosure Information StemRIM Announces Issuance of Stock Acquisition Rights as Stock Options to External Collaborators 
January 31, 2024 Timely Disclosure Information StemRIM Announces Patent Registration (Russia) for the Use of the HMGB1 Fragment Peptide, Redasemtide, as an Additional Therapeutic Indication of Cartilage Disorders (Traumatic Cartilage Deficiency Syndrome, Osteoarthritis, Disseverance Osteochondritis, etc.)  
December 28, 2023 Timely Disclosure Information StemRIM Announces Fixed Details of the Issuance of Stock Options to External Collaborator 
December 13, 2023 Timely Disclosure Information StemRIM Announces Issuance of Stock Acquisition Rights as Stock Options to External Collaborator 
December 6, 2023 Timely Disclosure Information StemRIM Announces Completion of Payment for Issuance of New Shares as Restricted Stock Compensation 
December 4, 2023 Timely Disclosure Information StemRIM Announces Conclusion of Agreement for the Initiation of a Phase2 Clinical Trial for Redasemtide in Ischemic Cardiomyopathy 
November 16, 2023 Timely Disclosure Information [Delayed]StemRIM Announces Issuance of New Shares as Remuneration for Restricted Stock 
November 16, 2023 Timely Disclosure Information [Delayed]StemRIM Announces Extension of the Tripartite Collaborative Research Agreement Updated on January 24, 2023 
October 27, 2023 Timely Disclosure Information [Delayed]StemRIM Announces Change of Representative Directors 
September 28, 2023 Timely Disclosure Information [Delayed]StemRIM Announces Proposal for Approval of Issuance of Stock Options to our Company’s Executive Officers, Employees, and External Collaborators 
September 28, 2023 Timely Disclosure Information StemRIM Announces Fixed Details of the Issuance of Stock Options to Temporary Employee and External collaborator 
September 20, 2023 Timely Disclosure Information [Delayed]StemRIM Announces Fixed Details of the Issuance of Stock Options to Employee  
September 20, 2023 Timely Disclosure Information [Delayed]StemRIM Announces Fixed Details of the Issuance of Stock Options to Director  
September 19, 2023 Timely Disclosure Information [Delayed]StemRIM Announces Issuance of Stock Acquisition Rights as Stock Options to Employee